HyunseokKangMDMPH, FACP
Oncology • San Francisco, CAEndocrine Cancer, Head & Neck Cancer
Associate Professor of Clinical Medicine, University of California San Francisco
Dr. Kang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Helen Diller Family Comprehensive Cancer Center
1825 4th Street
San Francisco, CA 94158Phone+1 415-885-7356Fax+1 415-333-7984- Is this information wrong?
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2007 - 2010
Yonsei University College of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2018 - 2025
MD State Medical License 2013 - 2018
GA State Medical License 2011 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2015
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations Start of enrollment: 2018 Dec 14
- A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies Start of enrollment: 2019 Feb 11
- A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) Start of enrollment: 2020 Mar 04
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsBiomarkers predictive of response to pembrolizumab in head and neck cancer.David G Pfister, Robert I Haddad, Francis P Worden, Jared Weiss, Ranee Mehra, Laura Q M Chow, Stephen V Liu, Hyunseok Kang, Nabil F Saba, Lori J Wirth, Ammar Sukari, E...> ;Cancer Medicine. 2023 Mar 1
- 11 citationsApproaches to the Management of Metastatic Adenoid Cystic Carcinoma.Rex H Lee, Katherine C Wai, Jason W Chan, Patrick K Ha, Hyunseok Kang> ;Cancers. 2022 Nov 20
- 100 citationsTumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2,...Vivek Subbiah, Jürgen Wolf, Bhavana Konda, Hyunseok Kang, Alexander Spira, Jared Weiss, Masayuki Takeda, Yuichiro Ohe, Saad Khan, Kadoaki Ohashi, Victoria Soldatenkova...> ;The Lancet. Oncology. 2022 Oct 1
- Join now to see all
Journal Articles
- Exceptional Responses to Pertuzumab, Trastuzumab, and Docetaxel in Human Epidermal Growth Factor Receptor‐2 High Expressing Salivary Duct CarcinomasLisa Rooper, Robert D Foss, Hyunseok Kang, Rishi Sawhney, Nicole C Schmitt, Head & Neck
- Pattern of Planned Systemic Therapy Usage in Newly Diagnosed, Nonmetastatic Squamous Cell Carcinoma of the Head and Neck in a Commercially Insured Population in the Un...Christine G Gourin, Ranee Mehra, Hyunseok Kang, Arlene A Forastiere, Ana P Kiess, Head & Neck
- Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1‐Deficient CarcinomaJosh Lauring, Lisa Rooper, Sarah Sagorsky, Hyunseok Kang, The Oncologist
Press Mentions
FDA Approves Pembrolizumab for Head and Neck CancerAugust 24th, 2016
Rivoceranib Elicits Promising Responses in Adenoid Cystic CarcinomaDecember 15th, 2022
Committees
- Member, Protocol Review Committee, UCSF Helen Diller Family Comprehensive Cancer Center 2022 - Present
- Member, Membership Committee, Society for Immunotherapy of Cancer 2019 - Present
- Co-director of Oncology Grand Rounds, Educational Committee, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2015 - 2018
- Member, Safety Monitoring Committee, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2015 - 2018
Professional Memberships
- Fellow
- Member
- Member
- Member
- Member
- Society for Immunotherapy of CancerMember
- International Thyroid Oncology Group (ITOG)Member
Other Languages
- Korean, Japanese
Hospital Affiliations
UCSF Medical CenterSan Francisco, California
External Links
- UCSFhttp://www.ucsf.edu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
